About Us

The Health Research Institute of Santiago de Compostela (IDIS) is a biomedical research center of marked translational character that takes advantage of the synergies of the University Clinical Hospital of Santiago de Compostela (CHUS) and the University of Santiago de Compostela (USC) to promote and encourage excellent research, scientific and technological knowledge and its subsequent transfer to the productive sector, as well as teaching and training, focused on a clear objective: to improve the people´s health. It was created on January 31, 2008, by means of a collaboration agreement between the Consellería de Sanidade, the Servizo Galego de Saúde and the University of Santiago de Compostela. Since March 2010, the IDIS holds an accreditation as research center issued by the Carlos III Health Institute (National Health System), extending such accreditation on May 18, 2015 and on March 10, 2020. Currently 1,213 people are integrated into 106 research groups, organized into 7 research areas: (A001) Oncology, (A002) Genetics and Systems Biology, (A003) Endocrinology, (A004) Neurosciences, (A005) Platforms and Methodology, (A006) Cardiovascular and (A007) Infectology, Inflammation and Vaccines.

In 2022, 1003 original scientific articles, editorials and reviews were published in 527 international journals indexed in the Journal Citation Report with a total impact index of 8,318 and an average impact index of 8.29. From those publications, 570 are in the first quartile (Q1) and of these, 192 are in D1. An amount of € 43,577,655.29 of funding, divided in 118 competitive research projects, 82 HR contracts/fellowships, 217 clinical studies and 375 contracts and collaboration agreements, has been acquired in 2022. In the educational field, IDIS researchers have carried out intense work, supervising 88 doctoral theses.